Astrana Health Sees Q2 Sales $965.000M-$1.000B vs $973.326M Est

Benzinga Newsdesk www.benzinga.com Positive 88.6%

Neg 0% Neu 0% Pos 88.6%

Astrana Health (NASDAQ:ASTH) sees Q2 sales of $965.000 million-$1.000 billion vs $973.326 million analyst estimate.

Comments

No comments yet. Be the first!